Cargando…
P1097: CD20 CAR-T THERAPY WITH MB-106 FOR BTK INHIBITOR-REFRACTORY WALDENSTRÖM MACROGLOBULINEMIA (WM)/ LYMPHOPLASMACYTIC LYMPHOMA (LPL) – SINGLE INSTITUTION STUDY
Autores principales: | Shadman, Mazyar, Yeung, Cecilia, Redman, Mary W, Yun Lee, Sang, Hoon Lee, Dong, Ra, Susan, Qian, David H, Dezube, Bruce, Chapuis, Aude, Green, Damian, Cowan, Andrew, Cassaday, Ryan, Kiem, Hans-Peter, Warren, Houston E, Milano, Filippo, Gauthier, Jordan, Hirayama, Alexandre, Kwok, Mary, Ujjani, Chaitra, Maloney, David, Gopal, Ajay, Till, Brian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430959/ http://dx.doi.org/10.1097/01.HS9.0000971284.68877.ca |
Ejemplares similares
-
Managing Waldenström’s macroglobulinemia with BTK inhibitors
por: Buske, Christian, et al.
Publicado: (2022) -
Current and novel BTK inhibitors in Waldenström’s macroglobulinemia
por: Ntanasis-Stathopoulos, Ioannis, et al.
Publicado: (2021) -
Cytogenetic aberrations of lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia in Chinese patients
por: Xiong, Wenjie, et al.
Publicado: (2023) -
Lung consolidation as a rare presentation of lymphoplasmacytic lymphoma with extramedullary Waldenström’s macroglobulinemia
por: Abdulfattah, Omar, et al.
Publicado: (2018) -
Lymphoplasmacytic lymphoma infiltrating both lacrimal glands in a patient with Waldenström's macroglobulinemia
por: Vangsted, Andreas, et al.
Publicado: (2020)